| Date Filed | Type | Description |
| 08/04/2023 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 60,000 options to buy
@ $1.13, valued at
$67.8k
|
|
| 06/29/2023 |
4
| Del Carmen Jeffrey (Chief Commercial Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 3,942 shares
@ $0
Exercised 10,000 restricted stock units
@ $0 |
|
| 06/05/2023 |
3
| Thompson Tamar (Director) has filed a Form 3 on CATALYST PHARMACEUTICALS, INC. |
| 05/17/2023 |
4
| MCENANY PATRICK J (President and CEO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Sold 26,151 shares
@ $13.23, valued at
$346k
Exercised 26,151 options to buy
@ $0.79, valued at
$20.7k
Exercised 173,849 options to buy
@ $0.79, valued at
$137.3k
|
|
| 05/16/2023 |
4
| Daly Richard J (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 50,000 options to buy
@ $0.79, valued at
$39.5k
|
|
| 05/12/2023 |
4
| Tierney David S (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 20,000 options to buy
@ $0.79, valued at
$15.8k
|
|
| 05/12/2023 |
4
| Miller Steve (COO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 100,000 options to buy
@ $0.79, valued at
$79k
|
|
| 05/05/2023 |
4
| COELHO PHILIP H (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 50,000 shares
@ $0.79, valued at
$39.5k
Granted 50,000 options to buy
@ $0.79, valued at
$39.5k
|
|
| 03/24/2023 |
4
| GRANDE ALICIA (VP, Treasurer and CFO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Sold 3,260 shares
@ $16.41, valued at
$53.5k
Sold 38,524 shares
@ $16.51, valued at
$636k
Exercised 3,260 options to buy
@ $0.79, valued at
$2.6k
Exercised 38,524 options to buy
@ $0.79, valued at
$30.4k
|
|
| 03/22/2023 |
4
| Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Sold 50,000 shares
@ $16.069, valued at
$803.5k
Exercised 50,000 options to buy
@ $1.13, valued at
$56.5k
|
|
| 01/27/2023 |
4
| O'Keeffe Charles B (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 50,000 options to buy
@ $0.79, valued at
$39.5k
|
|
| 01/27/2023 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 50,000 options to buy
@ $0.79, valued at
$39.5k
|
|
| 12/30/2022 |
4
| MCENANY PATRICK J (President and CEO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Gifted 10,000 shares
@ $0
Gifted 10,000 shares
@ $0 |
|
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| Tierney David S (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 15,000 options to buy
@ $18.59, valued at
$278.9k
Granted 4,000 restricted stock units
@ $0 |
|
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| MCENANY PATRICK J (President and CEO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 272,000 options to buy
@ $18.59, valued at
$5.1M
Granted 79,000 restricted stock units
@ $0 |
|
| 12/29/2022 |
4
| INGENITO GARY (Chief Medical Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 93,000 options to buy
@ $18.59, valued at
$1.7M
Granted 27,000 restricted stock units
@ $0 |
|
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 15,000 options to buy
@ $18.59, valued at
$278.9k
Granted 4,000 restricted stock units
@ $0 |
|
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| COELHO PHILIP H (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 15,000 options to buy
@ $18.59, valued at
$278.9k
Granted 4,000 restricted stock units
@ $0 |
|
| 12/08/2022 |
4
| Tierney David S (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 1,334 restricted stock units
@ $0 |
|
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2022 |
4
| MCENANY PATRICK J (President and CEO) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 12,133 shares
@ $0
Exercised 30,834 restricted stock units
@ $0 |
|
| 12/08/2022 |
4
| INGENITO GARY (Chief Medical Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Sold 5,918 shares
@ $16.85, valued at
$99.7k
Exercised 14,667 restricted stock units
@ $0 |
|
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2022 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 1,334 restricted stock units
@ $0 |
|
|